02 July 2020 : Clinical Research
Nuclear Factor κB/MicroRNA-155 Upregulates the Expression Pattern of Cytokines in Regulating the Relapse of Chronic Sinusitis with Nasal Polyps and the Underlying Mechanism of Glucocorticoid
Jianbin Du1BCE, Haijun Lv2BC, Xin Dou3BC, Zhongsheng Cao1ADEF*DOI: 10.12659/MSM.923618
Med Sci Monit 2020; 26:e923618
Table 1 Clinical characteristics of study patients.
| Items | Control | CRSsNP | Non-Eos CRSwNP | Eos CRSwNP |
|---|---|---|---|---|
| Number | 30 | 25 | 25 | 25 |
| Gender (Male/Female) | 18/12 | 17/8 | 13/12 | 16/9 |
| Age (years) | 38.8±7.5 | 40.4±8.3 | 40.8±8.9 | 42.1±8.2 |
| Positive for Phadiatop, n (%) | 1 (3.3%) | 3 (12.0%) | 5 (20.0%) | 6 (24.0%) |
| Positive for asthma, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Smoking history, n (%) | 8 (26.7%) | 7 (25.0%) | 10 (40.0%) | 9 (36.0%) |
| Aspirin intolerance triad | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| CRSsNP – chronic rhinosinusitis without nasal polyps; Non-Eos CRSwNP – non-eosinophilic chronic rhinosinusitis with nasal polyps; Eos CRSwNP – eosinophilic chronic rhinosinusitis with nasal polyps. | ||||